185 related articles for article (PubMed ID: 23463096)
1. Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment.
Li X; Li Y; Wang B; Ji K; Liang Z; Guo B; Hu J; Yin D; Du Y; Kopecko DJ; Kalvakolanu DV; Zhao X; Xu D; Zhang L
J Cancer Res Clin Oncol; 2013 Jun; 139(6):971-80. PubMed ID: 23463096
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.
Tian Y; Guo B; Jia H; Ji K; Sun Y; Li Y; Zhao T; Gao L; Meng Y; Kalvakolanu DV; Kopecko DJ; Zhao X; Zhang L; Xu D
Cancer Gene Ther; 2012 Jun; 19(6):393-401. PubMed ID: 22555509
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.
Zhang L; Gao L; Zhao L; Guo B; Ji K; Tian Y; Wang J; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Cancer Res; 2007 Jun; 67(12):5859-64. PubMed ID: 17575154
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma.
Jia H; Li Y; Zhao T; Li X; Hu J; Yin D; Guo B; Kopecko DJ; Zhao X; Zhang L; Xu DQ
Cancer Immunol Immunother; 2012 Nov; 61(11):1977-87. PubMed ID: 22527247
[TBL] [Abstract][Full Text] [Related]
5. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
6. Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.
Liu YB; Zhang L; Guo YX; Gao LF; Liu XC; Zhao LJ; Guo BF; Zhao LJ; Zhao XJ; Xu DQ
Asian J Androl; 2012 Jul; 14(4):536-45. PubMed ID: 22580637
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo.
Liang ZW; Guo BF; Li Y; Li XJ; Li X; Zhao LJ; Gao LF; Yu H; Zhao XJ; Zhang L; Yang BX
Asian J Androl; 2011 May; 13(3):481-6. PubMed ID: 21297658
[TBL] [Abstract][Full Text] [Related]
9. [Construction of RNA recombinant vector expressing STAT3 short hairpin and its effects on proliferation and apoptosis of SiHa cells].
Wu WG; Yu YC; Chen YQ; Cao XQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):986-8. PubMed ID: 18845085
[TBL] [Abstract][Full Text] [Related]
10. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.
Li J; Piao YF; Jiang Z; Chen L; Sun HB
World J Gastroenterol; 2009 Jun; 15(21):2602-8. PubMed ID: 19496189
[TBL] [Abstract][Full Text] [Related]
11. [Double suicide gene therapy with RNAi targeting to STAT3 inhibits the growth of colorectal carcinoma cells in vitro].
Chen JY; Luo B; Guo XB; Wan LH
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):91-6. PubMed ID: 21575474
[TBL] [Abstract][Full Text] [Related]
12. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
Fu W; Chu L; Han X; Liu X; Ren D
J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.
Pan Y; Zhang L; Zhang X; Liu R
Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630
[TBL] [Abstract][Full Text] [Related]
15. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
16. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
[TBL] [Abstract][Full Text] [Related]
17. Local effects of retrovirally transduced endostatin-expressing human umbilical cord blood CD34+ cells on transplanted malignancy in a mouse model of hepatic cancer.
Jiang Z; Teng GJ; Chen BA; Xu ZF; Hu J; Shao ZY
Cell Transplant; 2008; 17(8):969-75. PubMed ID: 19069638
[TBL] [Abstract][Full Text] [Related]
18. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z
Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of prostate cancer RM1 cell growth in vitro by hydroxyapatite nanoparticle‑delivered short hairpin RNAs against Stat3.
Liang Z; Wang H; Guo B; Li F; Liu J; Liu Z; Xu L; Yun W; Zhao X; Zhang L
Mol Med Rep; 2017 Jul; 16(1):459-465. PubMed ID: 28534932
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
